MedPath

Effects of transfusion of leukocyte-depleted erythrocytes in cardiac valve surgery on postoperative complications.

Completed
Conditions
Cardiac valve surgery +/- CABG.
Registration Number
NL-OMON25360
Lead Sponsor
Dutch Heart Foundation, No 98.183.
Brief Summary

Circulation. 2004 Jun 8;109(22):2755-60.<br> Transfus Med. 2005 Jun;15(3):209-17.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
496
Inclusion Criteria

Patients undergoing valve surgery (+/- CABG).

Exclusion Criteria

Patients under 18 years of age, patients with medical indications for leucocyte-depleted erythrocytes and who received blood transfusions within previous 3 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
90-days mortality and causes of deaths.
Secondary Outcome Measures
NameTimeMethod
1. In-hospital mortality, 30- and 60-days mortality, onset and type of postoperative infections, onset and type of multiple-organ-dysfunction-syndrome (MODS), ICU-stay, hospital-stay and long-term survival. Pro-and anti-inflammatory cytokine profile, complement system activation and inflammatory mediators. <br /><br>2. Cost-effective-analysis for the primary outcome.
© Copyright 2025. All Rights Reserved by MedPath